Endothelin-1 (ET-1) contributes to senescence and phenotypic changes in brain pericytes in diabetes-mimicking conditions
Open Access
- 21 August 2024
- journal article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 138 (16) , 1009-1022
Abstract
Diabetes mediates endothelial dysfunction and increases the risk of Alzheimer’s disease and related dementias. Diabetes also dysregulates the ET system. ET-1-mediated constriction of brain microvascular pericytes (BMVPCs) has been shown to contribute to brain hypoperfusion. Cellular senescence, a process that arrests the proliferation of harmful cells and instigates phenotypical changes and proinflammatory responses in endothelial cells that impact their survival and function. Thus, we hypothesized that ET-1 mediates BMVPC senescence and phenotypical changes in diabetes-like conditions. Human BMVPCs were incubated in diabetes-like conditions with or without ET-1 (1 µmol/L) for 3 and 7 days. Hydrogen peroxide (100 µmol/L H2O2) was used as a positive control for senescence and to mimic ischemic conditions. Cells were stained for senescence-associated β-galactosidase or processed for immunoblotting and quantitative real-time PCR analyses. In additional experiments, cells were stimulated with ET-1 in the presence or absence of ETA receptor antagonist BQ-123 (20 μmol/L) or ETB receptor antagonist BQ-788 (20 μmol/L). ET-1 stimulation increased β-galactosidase accumulation which was prevented by BQ-123. ET-1 also increased traditional senescence marker p16 protein and pericyte-specific senescence markers, TGFB1i1, PP1CA, and IGFBP7. Furthermore, ET-1 stimulated contractile protein α-SMA and microglial marker ostepontin in high glucose suggesting a shift toward an ensheathing or microglia-like phenotype. In conclusion, ET-1 triggers senescence, alters ETA and ETB receptors, and causes phenotypical changes in BMVPCs under diabetes-like conditions. These in vitro findings need to be further studied in vivo to establish the role of ETA receptors in the progression of pericyte senescence and phenotypical changes in VCID.Keywords
Funding Information
- Veterans Affairs (VA) Merit Review (BX000347)
- VA Senior Research Career Scientist Award (IK6 BX004471)
- National Institute of Health (RF1 NS083559)
- National Institute of Health (R01 NS104573)
- NINDS-Diversity Supplement (RF1 NS083559S2)
This publication has 62 references indexed in Scilit:
- Microglia directly associate with pericytes in the central nervous systemGlia, 2023
- The Active Role of Pericytes During Neuroinflammation in the Adult BrainCellular and Molecular Neurobiology, 2022
- Interplay between Brain Pericytes and Endothelial Cells in DementiaThe American Journal of Pathology, 2021
- Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic StrokeCNS Drugs, 2021
- Aging exacerbates impairments of cerebral blood flow autoregulation and cognition in diabetic ratsGeroScience, 2020
- Single-cell RNA sequencing identifies senescent cerebromicrovascular endothelial cells in the aged mouse brainGeroScience, 2020
- Markers for human brain pericytes and smooth muscle cellsJournal of Chemical Neuroanatomy, 2018
- Pericytes in diabetes-associated vascular diseaseJournal of Diabetes and its Complications, 2016
- Type IV Collagens and Basement Membrane Diseases2015
- Brain pericytes acquire a microglial phenotype after strokeActa Neuropathologica, 2014